🚚 Free shipping on all orders above $299 · 30 days money back guarantee · Helpline +1 251-332-4105

Leuprolide Acetate 1 mg

$63.00$12.60 per ing · 5 ings

Lupride Injection helps treat prostate cancer, endometriosis & infertility. Order at the best price in the US, UK & Australia today!

Choose pack sizePrice per ing shown

Want to order in bulk / B2B price?

Tracked, discreet delivery

Ships in discreet packaging with a tracking number. Free shipping on orders above $299.

30 days money back guarantee

Damaged, missing or only part of your order arrived? Choose a new package or a full refund.

Questions before you order?

Call +1 251-332-4105 or email order@pharmeasybank.com.

SECURE CHECKOUT
DISCOVER
MasterCard
VISA

Share

What Is Leuprolide Acetate 1 mg?

Leuprolide Acetate 1 mg is described as an injectable hormonal medicine containing leuprolide acetate, a synthetic analogue of naturally occurring gonadotropin-releasing hormone (GnRH).

GnRH is produced by the hypothalamus and helps regulate the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland.

These hormones control important reproductive and endocrine functions, including testosterone production in males and estrogen production in females.

Leuprolide initially stimulates GnRH receptors in the pituitary gland.

However, when administered continuously rather than in the body’s normal pulsatile pattern, it causes receptor desensitization and suppression of LH and FSH secretion.

This subsequently reduces testosterone production in males and ovarian estrogen production in females.

The hormonal suppression produced by leuprolide is useful in selected hormone-sensitive medical conditions.

Certain leuprolide formulations are approved for the palliative treatment of advanced prostate cancer.

Other specific formulations are used for conditions such as endometriosis, uterine fibroids and central precocious puberty.

Leuprolide is also used in selected reproductive medicine protocols under specialist supervision.

However, these indications cannot automatically be applied to every leuprolide product or strength.

Daily 1 mg formulations and long-acting depot formulations may have different approved uses, dosing schedules and administration requirements.

Important: Leuprolide acetate is not conventional cytotoxic chemotherapy. It is a hormonal treatment that changes the body’s production of sex hormones.

How Does Leuprolide Acetate 1 mg Work?

1. Acts as a GnRH Agonist

Leuprolide binds to gonadotropin-releasing hormone receptors in the pituitary gland.

2. Initially Stimulates Hormone Release

During the early treatment period, leuprolide temporarily increases LH and FSH secretion.

This can cause a temporary rise in testosterone or estrogen levels.

3. Produces an Initial Hormonal Flare

The temporary increase in hormone levels is commonly called the hormonal flare effect.

In patients with advanced prostate cancer, this may temporarily worsen certain cancer-related symptoms.

4. Desensitizes Pituitary GnRH Receptors

Continuous exposure to leuprolide reduces the pituitary gland’s responsiveness to GnRH stimulation.

5. Suppresses LH and FSH Secretion

After receptor desensitization, LH and FSH secretion decreases.

6. Reduces Testosterone Production

In males, suppression of LH reduces testosterone production by the testes.

This is important in treating testosterone-dependent prostate cancer.

7. Reduces Estrogen Production

In females, suppression of gonadotropins reduces ovarian estrogen production.

This mechanism is relevant to selected gynecological indications.

8. Produces Sustained Hormonal Suppression

With appropriate continued administration, leuprolide maintains suppression of sex hormone production.

Important: Hormonal suppression is generally reversible after treatment discontinuation, but recovery time varies and may be prolonged depending on treatment duration, formulation and individual factors.

Uses of Leuprolide Acetate 1 mg

1. Advanced Prostate Cancer

Certain daily leuprolide acetate injection formulations are used for the palliative treatment of advanced prostate cancer.

Lowering testosterone levels can help control the growth of testosterone-dependent prostate cancer cells.

2. Hormone-Sensitive Prostate Cancer Management

Leuprolide may form part of androgen deprivation therapy (ADT) for selected patients with prostate cancer.

3. Testosterone Suppression

Leuprolide suppresses testosterone production following the initial hormonal flare.

This effect is central to its role in prostate cancer treatment.

4. Endometriosis

Certain leuprolide formulations are used for the management of endometriosis.

Reduced estrogen production can help decrease endometriosis-related pain.

However, the indication and regimen must be verified for the exact product.

5. Uterine Fibroids

Specific leuprolide formulations may be used in selected patients with uterine fibroids, including preoperative management of fibroid-related anemia.

Treatment duration and use of additional hormonal medicines depend on the approved regimen.

6. Central Precocious Puberty

Certain pediatric leuprolide formulations are used to treat central precocious puberty.

These formulations have specific pediatric dosing and monitoring requirements.

7. Assisted Reproductive Technology

Leuprolide may be used in specialist-controlled fertility treatment protocols to regulate pituitary hormone activity.

The use, timing and dose depend on the reproductive medicine protocol.

8. Hormonal Suppression in Selected Clinical Settings

Leuprolide may be used when temporary suppression of gonadal hormone production is clinically appropriate.

9. Long-Term Androgen Deprivation Therapy

In selected prostate cancer patients, leuprolide may be continued as part of long-term hormonal management.

10. Individualized Hormonal Treatment

Treatment may be selected according to the underlying condition, hormone levels, patient characteristics and specialist recommendations.

Important: The 1 mg daily injection formulation should not be advertised as approved for endometriosis, uterine fibroids, fertility treatment or central precocious puberty unless the exact product labeling supports that indication.

How to Take Leuprolide Acetate 1 mg

Leuprolide acetate is an injectable medicine that must be administered according to the specific formulation and prescribing instructions.

General Administration Instructions

  1. Confirm the exact product name, strength and concentration.
  2. Verify whether the product is a daily injection or depot preparation.
  3. Follow the specialist’s prescribed dose and schedule.
  4. Use only the approved administration route.
  5. Follow the healthcare professional’s injection instructions.
  6. Do not substitute one leuprolide formulation for another.
  7. Use a new sterile needle and syringe when required.
  8. Rotate injection sites according to product instructions.
  9. Dispose of used needles in an appropriate sharps container.
  10. Attend scheduled medical appointments and laboratory monitoring.

Is Leuprolide Acetate 1 mg Taken Daily?

Certain leuprolide acetate injection products are administered once daily.

Long-acting depot products have entirely different administration intervals.

Is Leuprolide Given Subcutaneously?

Certain daily leuprolide formulations are administered by subcutaneous injection.

Other formulations may require intramuscular or subcutaneous administration depending on the product.

Can Leuprolide Be Self-Injected?

Some daily injection products may be administered at home after appropriate training.

Self-injection should only occur when authorized by the treating healthcare professional.

Can Leuprolide Be Taken Orally?

No. Leuprolide acetate injection products are not intended for oral administration.

What If a Dose Is Missed?

Contact the treating healthcare professional for product-specific missed-dose instructions.

Do not double the next dose without medical advice.

What If Too Much Leuprolide Is Administered?

Seek medical advice immediately.

The appropriate response depends on the formulation, amount administered and clinical circumstances.

How Long Does Leuprolide Acetate Take to Work?

The response depends on the formulation, indication and individual hormonal response.

During the First Several Days

Leuprolide initially stimulates pituitary hormone release.

This may temporarily increase testosterone or estrogen levels.

During the First Few Weeks

With continued administration, pituitary hormone secretion becomes suppressed.

During Prostate Cancer Treatment

Testosterone suppression generally develops over the first several weeks.

Clinical monitoring is necessary to confirm an adequate response.

During Continued Hormonal Therapy

Sustained treatment maintains suppression of gonadal hormone production.

Important: Leuprolide does not immediately suppress testosterone or estrogen after the first dose. The initial hormonal flare is an important treatment consideration.

Common Side Effects

Possible side effects include:

  • Hot flashes
  • Increased sweating
  • Injection-site discomfort
  • Injection-site redness
  • Headache
  • Fatigue
  • Dizziness
  • Nausea
  • Joint discomfort
  • Muscle discomfort
  • Changes in sexual desire
  • Erectile dysfunction
  • Mood changes
  • Sleep disturbances
  • Weight changes
  • Reduced energy
  • Menstrual changes in applicable patients

The frequency and severity of adverse effects depend on the patient’s sex, treatment indication, duration and formulation.

Serious Side Effects

Seek urgent medical attention if any of the following occur:

  • Severe allergic reactions
  • Chest pain
  • Sudden shortness of breath
  • Symptoms of stroke
  • Severe headache with neurological symptoms
  • Seizures
  • Severe depression or suicidal thoughts
  • New or worsening bone pain
  • Difficulty passing urine
  • New weakness or numbness in the legs
  • Severe back pain with neurological symptoms
  • Significant changes in blood glucose
  • Severe injection-site reactions

Important Serious Risks

Initial Tumor Flare: Temporary testosterone elevation may worsen symptoms in patients with advanced prostate cancer.

Spinal Cord Compression: In susceptible prostate cancer patients, tumor flare may contribute to serious neurological complications.

Urinary Tract Obstruction: Temporary worsening of urinary obstruction may occur during early prostate cancer treatment.

Bone Mineral Density Loss: Long-term suppression of sex hormones may reduce bone density and increase fracture risk.

Cardiovascular Events: Androgen deprivation therapy may be associated with increased cardiovascular risk in certain patients.

Hyperglycemia and Diabetes: Changes in glucose metabolism may occur during treatment.

QT Interval Prolongation: Androgen deprivation therapy may prolong the QT interval in susceptible patients.

Psychiatric Effects: Mood changes and depression may occur.

Seizures: Seizures have been reported in patients receiving GnRH agonists.

Pituitary Apoplexy: Rare cases of pituitary apoplexy have been reported after GnRH agonist administration.

Severe Cutaneous Adverse Reactions: Rare serious skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported with GnRH agonists.

Contraindications & Precautions

1. Allergy to Leuprolide

Patients with known serious hypersensitivity to leuprolide, other GnRH analogues or formulation ingredients should not use the medicine.

2. Pregnancy

Leuprolide can cause fetal harm and is contraindicated during pregnancy for relevant formulations and indications.

3. Breastfeeding

Breastfeeding is generally not recommended during treatment.

4. Initial Hormonal Flare

Patients with advanced prostate cancer may experience temporary worsening of symptoms during early treatment.

5. Spinal Cord Compression Risk

Patients with vertebral metastases require close monitoring during the initial treatment period.

6. Urinary Obstruction

Patients with existing urinary tract obstruction may be at increased risk of complications during hormonal flare.

7. Bone Mineral Density

Long-term treatment can reduce bone density.

8. Osteoporosis

Patients with osteoporosis or fracture risk factors may require additional monitoring and preventive measures.

9. Cardiovascular Disease

Patients with heart disease or cardiovascular risk factors require individualized assessment.

10. Diabetes

Blood glucose may increase during treatment.

11. QT Interval Prolongation

Patients with QT prolongation, electrolyte abnormalities or interacting medicines may require ECG monitoring.

12. Depression and Mood Disorders

Mood changes and depression should be monitored.

13. Seizure Disorders

Patients with seizure disorders or other neurological risk factors require appropriate assessment.

14. Pituitary Disorders

Rare pituitary complications have been reported after GnRH agonist administration.

15. Drug Interactions

Important considerations include:

  • Medicines that prolong the QT interval
  • Medicines affecting blood glucose control
  • Other hormonal therapies
  • Drugs used for androgen deprivation
  • Medicines that increase osteoporosis risk

Leuprolide does not have the same extensive CYP-mediated interaction profile as many oral anticancer medicines, but the full medication list should still be reviewed.

16. Fertility and Reproductive Effects

Leuprolide suppresses reproductive hormone production and may affect fertility during treatment.

Recovery after discontinuation varies.

17. Formulation Interchangeability

Daily injections and depot formulations are not automatically interchangeable.

18. Medical Monitoring

Healthcare professionals may assess:

  • Treatment indication
  • Testosterone levels
  • Estradiol levels when indicated
  • LH and FSH levels when indicated
  • PSA levels during prostate cancer treatment
  • Cancer-related symptoms
  • Bone mineral density
  • Mood changes
  • Neurological symptoms
  • Injection-site reactions
  • Menstrual status when applicable
  • Pregnancy status when applicable
  • Treatment response
  • Need for ongoing therapy
  • Adverse effects

Potential Therapeutic Advantages

  • GnRH Agonist Activity.
  • Hormonal Suppression.
  • Testosterone Reduction.
  • Estrogen Suppression.
  • Selected Prostate Cancer Treatment.
  • Multiple Formulation Options.
  • Hormone-Responsive Disease Management.
  • Laboratory-Guided Treatment.
  • Individualized Treatment Planning.

Disadvantages / Limitations

  • Requires Injection.
  • Potential Osteoporosis Risk.
  • Potential Cardiovascular Risks.
  • Possible Blood Glucose Elevation.
  • Possible QT Interval Prolongation.
  • Rare Seizure Risk.
  • Rare Pituitary Apoplexy.
  • Potential Fertility Effects.
  • Pregnancy-Related Harm.
  • Requires Specialist Supervision.
  • Requires Hormonal Monitoring.
  • Formulations Are Not Interchangeable.
  • Does Not Guarantee a Cure for Cancer.

Important Notes

Generic Name: Leuprolide Acetate.

Alternative Name: Leuprorelin Acetate.

Administration Frequency: Product-Specific.

Storage: Follow Original Product Labeling.

Frequently Asked Questions

1. What is Leuprolide Acetate 1 mg used for?

Certain daily leuprolide acetate injection formulations are used for the palliative treatment of advanced prostate cancer. Other leuprolide products have different approved indications.

2. Is Leuprolide Acetate a chemotherapy medicine?

No. Leuprolide is a hormonal medicine classified as a GnRH agonist.

3. How does Leuprolide Acetate work?

It initially stimulates GnRH receptors and then suppresses LH and FSH secretion with continued administration, reducing testosterone or estrogen production.

4. Is Leuprolide used for prostate cancer?

Yes. Certain leuprolide formulations are used as part of androgen deprivation therapy for prostate cancer.

5. Does Leuprolide reduce testosterone?

Yes. Continued treatment suppresses testosterone production after an initial temporary increase.

6. What is the hormonal flare effect?

Hormonal flare is a temporary increase in sex hormone levels during the early phase of GnRH agonist treatment.

7. Is Leuprolide Acetate 1 mg given daily?

Certain daily injection products are administered once daily. The exact schedule depends on the formulation.

8. Is Leuprolide given by injection?

Yes. Leuprolide is available in injectable formulations with different administration routes and schedules.

Product DetailsInformation
Product NameLeuprolide Acetate 1 mg
Generic NameLeuprolide Acetate (Leuprorelin Acetate)
Active IngredientLeuprolide Acetate
Strength1 mg – Verify Whether This Refers to the Dose or Concentration
Dosage FormInjectable Solution – Formulation Must Be Verified
Drug ClassGonadotropin-Releasing Hormone (GnRH) Agonist
Therapeutic CategoryHormonal Therapy / Endocrine Therapy
Primary UsesSelected Prostate Cancer Treatment Regimens; Other Formulation-Specific Hormonal Indications
Mechanism of ActionContinuous GnRH Receptor Stimulation Followed by Suppression of Gonadotropin Secretion
Route of AdministrationUsually Subcutaneous for Certain Daily Formulations
Typical FrequencyDepends on the Exact Product and Indication
Treatment DurationDetermined by the Treating Specialist
Brand NameNot Specified
ManufacturerVerify Original Packaging
Pack SizeVerify Original Packaging
Prescription StatusPrescription-Only Medicine
StorageFollow Product-Specific Labeling
Medical SupervisionOncology, Urology, Endocrinology or Reproductive Medicine Specialist
Pack sizes5 ings, 10 ings, 15 ings
Bulk / B2B price inquiry

Tell us what you need and we’ll reply by email.